ONCT

Oncternal Therapeutics, Inc. Common Stock

Delisted

ONCT was delisted on the 2nd of December, 2024.

52 hedge funds and large institutions have $3.26M invested in Oncternal Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
-2
Holders Change %
-3.7%
% of All Funds
0.82%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
9
Reduced
11
Closed
7
Calls
$4K
Puts
Net Calls
+$4K
Net Calls Change
-$3K
Name Holding Trade Value Shares
Change
Shares
Change %
JPMorgan Chase & Co
51
JPMorgan Chase & Co
New York
$9
DAM
52
Delta Asset Management
Tennessee
$2 -$6
BC
53
BIT Capital
Germany
-$566K -36,673 Closed
CWA
54
CM Wealth Advisors
Ohio
-$16K -2,782 Closed
HCM
55
Hollencrest Capital Management
California
-$8.64K -550 Closed
Simplex Trading
56
Simplex Trading
Illinois
-$5K -356 Closed
Citadel Advisors
57
Citadel Advisors
Florida
-$3.07K -196 Closed
Fidelity Investments
58
Fidelity Investments
Massachusetts
-$970 -62 Closed
GGI
59
Godsey & Gibb Inc
Virginia
-$15 -1 Closed